Phathom Pharmaceuticals (PHAT) Gross Profit (2023 - 2026)
Phathom Pharmaceuticals (PHAT) posted quarterly Gross Profit of $59.2 million for Q2 2026, up 71.7% year-over-year from $34.5 million in Q2 2025, and up 27.8% quarter-over-quarter from $46.3 million in Q1 2026.
Phathom Pharmaceuticals (PHAT) Gross Profit (2023 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported Gross Profit for 4 consecutive years, with $59.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Gross Profit rose 71.7% year-over-year to $59.2 million; the TTM figure through Jun 2026 stood at $198.7 million (up 100.53% YoY), while the FY2025 annual figure was $152.5 million, up 222.58% from the prior year.
- Gross Profit improved to $59.2 million in Q2 2026 per PHAT's latest filing, from $46.3 million in the prior quarter.
- Across five years, Gross Profit topped out at $59.2 million in Q2 2026 and bottomed at $515000.0 in Q4 2023.
- Historically, Gross Profit has averaged $27.8 million across 4 years, with a median of $25.8 million in 2024.
- Annual changes were most pronounced in 2024 — Gross Profit surged 4919.22% — and 2026, when it jumped 71.7%.
- Phathom Pharmaceuticals' Gross Profit stood at $515000.0 in 2023, then soared by 4919.22% to $25.8 million in 2024, then jumped by 93.18% to $49.9 million in 2025, then increased by 18.51% to $59.2 million in 2026.
- Business Quant data shows PHAT's Gross Profit at $59.2 million in Q2 2026, $46.3 million in Q1 2026, and $49.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Phathom Pharmaceuticals | 767.07 Mn | 581.73 Mn | 59.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.18 Mn |
| Jun 30, 2026 | 59.18 Mn |
| Mar 31, 2026 | 46.31 Mn |
| Mar 31, 2026 | 46.31 Mn |
| Dec 31, 2025 | 49.94 Mn |
| Dec 31, 2025 | 49.94 Mn |
| Sep 30, 2025 | 43.31 Mn |
| Sep 30, 2025 | 43.31 Mn |
| Jun 30, 2025 | 34.47 Mn |
| Jun 30, 2025 | 34.47 Mn |
| Mar 31, 2025 | 24.80 Mn |
| Mar 31, 2025 | 24.80 Mn |
| Dec 31, 2024 | 25.85 Mn |
| Dec 31, 2024 | 25.85 Mn |
| Sep 30, 2024 | 14.00 Mn |
| Sep 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.49 Mn |